Dawn Brown, MD
Psychiatry · Gardena
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 20 years
- Saint Louis University School of Medicine, 2006
Offices
3 locations · Ehab Yacoub MD Inc · 179 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Brown’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence C188157 · Current
Licensed to practise in California · since 2023 · expires 2027-07-31 · Saint Louis University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
2 licences
- Illinois 036143040Licensed Physician And Surgeon · since 2017 · expires 2029-07-31ActiveNo board action on this licenceCheck it with the state
- Texas N7527Physician License · since 2010 · expires 2027-08-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Child and Adolescent Psychiatry
- American Board of Psychiatry and Neurology - Psychiatry
Medicaid work
$26,637 in 2024
Medicaid paid $26,637 for 216 billed services this clinician did in 2024, up to 36 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 130 | $18,205 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 70 | $6,556 |
| Psychotherapy, 45 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 16 | $1,877 |
| 2024 | 216 | 3 | 36 | $26,637 |
| 2023 | 256 | 3 | 41 | $25,263 |
| 2021 | 24 | 2 | 12 | $1,277 |
| 2020 | 15 | 1 | 13 | $287 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 154 | $17,048 |
| Psychiatric diagnostic evaluation with medical services | 65 | $8,215 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 37 | $0 |
2021
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 12 | $661 |
| Return visit (30+ min) | 12 | $617 |
2020
| Telehealth originating site facility fee | 15 | $287 |
Drugs they prescribed that Part D paid
$5,480
Pharmacies billed $5,480 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 186) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
186 generic and 0 brand-name prescriptions · $5,480 in drug cost · 12 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lurasidone | 14 | $3,486 | $249 |
| Quetiapine | 22 | $802 | $36 |
| Fluoxetine | 18 | $284 | $16 |
| Buspirone | 30 | $269 | $9 |
| Sertraline | 44 | $83 | $2 |
See all 6 drugs
| Lurasidone | 14 | $3,486 | $249 |
| Quetiapine | 22 | $802 | $36 |
| Fluoxetine | 18 | $284 | $16 |
| Buspirone | 30 | $269 | $9 |
| Sertraline | 44 | $83 | $2 |
| Lamotrigine | 19 | $58 | $3 |
Year by year
| 2024 | 186 | 18 | 0% (0) | 0% | $5,480 |
| 2023 | 161 | 22 | 0% (0) | None | $13,653 |
| 2022 | 36 | None | 0% (0) | None | $3,246 |
| 2021 | 55 | None | 0% (0) | 22% | $4,510 |
| 2020 | 33 | None | 0% (0) | None | $2,063 |
| 2019 | 25 | None | 0% (0) | 0% | $597 |
| 2018 | 109 | 31 | 0% (0) | None | $23,201 |
| 2017 | 215 | 71 | 0% (0) | 15% | $133,782 |
| 2015 | 16 | None | None | None | $270 |
| 2014 | 171 | 13 | None | 11% | $6,125 |
| 2013 | 268 | 28 | 0% (0) | 25% | $26,362 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Buspirone | 17 | $375 | $22 |
| Quetiapine | 15 | $371 | $25 |
| Fluoxetine | 20 | $144 | $7 |
| Risperidone | 16 | $123 | $8 |
| Lamotrigine | 12 | $122 | $10 |
| Benztropine Mesylate | 13 | $80 | $6 |
2022: 1 drug
| Fluoxetine | 12 | $105 | $9 |
2021: 4 drugs
| Vyvanse | 12 | $4,121 | $343 |
| Fluoxetine | 12 | $105 | $9 |
| Methylphenidate | 11 | $96 | $9 |
| Clonidine | 14 | $89 | $6 |
2018: 2 drugs
| Buspirone | 12 | $202 | $17 |
| Sertraline | 14 | $127 | $9 |
2017: 6 drugs
| Lidocaine | 44 | $40,553 | $922 |
| Fluocinonide | 15 | $24,100 | $1,607 |
| Doxepin | 19 | $22,291 | $1,173 |
| Fluocinolone Acetonide | 14 | $10,545 | $753 |
| Calcipotriene | 11 | $8,961 | $815 |
| Alcohol Pads | 22 | $994 | $45 |
2014: 4 drugs
| Diazepam | 35 | $219 | $6 |
| Lamotrigine | 13 | $93 | $7 |
| Sertraline | 12 | $73 | $6 |
| Zolpidem | 13 | $48 | $4 |
2013: 10 drugs
| Saphris | 11 | $6,199 | $564 |
| Lunesta | 17 | $4,248 | $250 |
| Ziprasidone | 14 | $3,695 | $264 |
| Fluoxetine | 26 | $685 | $26 |
| Risperidone | 11 | $415 | $38 |
| Alprazolam | 30 | $375 | $12 |
| Lamotrigine | 20 | $278 | $14 |
| Sertraline | 12 | $126 | $11 |
| Trazodone | 13 | $93 | $7 |
| Clonazepam | 12 | $89 | $7 |
Money from drug and device companies
$48 in 2022
| 2022 | 1 | 2 | None | $48 |
| 2021 | 1 | 1 | None | $19 |
| 2019 | 1 | 1 | None | $16 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Supernus Pharmaceuticals | Qelbree | $48 | 2 payments
|
See all 2 published payments
| Supernus Pharmaceuticals | Meals · 2022-03-16 | Qelbree | $23 |
| Supernus Pharmaceuticals | Meals · 2022-01-26 | Qelbree | $25 |
See earlier years (2021, 2019)
2021: $19
| Adlon Therapeutics L.P. | Adhansia Xr | $19 | 1 payment
|
2019: $16
| Allergan | Vraylar | $16 | 1 payment
|
Professional record
- NPI
- 1740481118
- Licence
- CA C188157, IL 036143040, TX N7527California C188157: Current · expires 2027-07-31Illinois 036143040: ActiveTexas N7527: Active
- Trained
- Saint Louis University School of Medicine, 2006 · 20 years ago
- Group
- Ehab Yacoub MD Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2084P0804X (2084P0804X); Psychiatry (2084P0800X)
- Mailing address
- 1215 Hickory St Unit E, Houston, TX, 77007
- NPI first listed
- 2007-05-31
- NPI last updated
- 2025-11-20
- NPI record certified
- 2025-11-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5002 W Madison St, Chicago, IL, 60644 · 1215 Hickory St Unit E, Houston, TX, 77007 · 7877 Willow Chase Blvd # 77070, Houston, TX, 77070 · 902 Frostwood Dr Ste 201, Houston, TX, 77024 · 23838 Highway 59 N, Kingwood, TX, 77339